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2 INTRODUCTION  . 
(1)  The announcement made by the United Kingdom authorities on 20 March 1996 
that a link between bovine spongiform encephalopathy (BSE) and  Creutzfeldt-
Jacob Disease (CJD) could not be ruled out provoked an unprecedented crisis of 
confidence among European consumers with regard to beef and bovine products. · 
Since then, a flood of contradictory and often incomplete information has merely 
am,plified these concerns. 
(2)  It is appropriate, then, to inform consumers about the situation and the measures 
to reinforce consumer safety which have been taken or which are envisaged in 
the  framework  of the  European  Union  and  to  try  to  outline  the  scientific . 
uncertainties at the root of the crisis.  This briefing, which incorporates, updates 
and  supplements  the  guide of 28 May 1996
1
,  . and  which was  prepared  by the 
Interdepartmental  Working  Party  established  by  the  Commission  on 
27 March 1996, sets out to do just that. 
I  A.  WHATISBSE?' 
(3)  Bovine  spongiform  encephalopathy  (BSE)  is  a  degenerative  brain  disease 
affecting  cattle.  This  is  a  new  disease,  since  the  first  case  was  officially 
recognised in the United Kingdom in 1986, 10 years ago. It belongs to the family 
of transmissible spongiform  encephalopathies,  which  in  animals  include  sheep 
and goat scrapie,  mink spongiform encephalopathy and the encephalopathies of 
the cat and certain wild animals 'raised in captivity. 
(  4)  The United Kingdom epizootic had affected 442 animals by the end of 1987, a 
figure which rose rapidly to a maximum annual  in~idence of over 3  7 000 cases in 
1992
2
. With the introduction of control measures, the annual incidence has fallen 
by  over  60% ·in three  years  to  approximately  14  000  cases  in  1995.  This 
downward trend is continuing, the estimated incidence for 1996 being less than 8 
500.  The United Kingdom  has  had  a total  of almost  165 000  cases
2  affecting 
almost  34 000  farms.  In  other  countries,  the  total  number  ·of  cases  is 
approximately  500,  half of these  being  in  Switzerland  and. the  rest  in  other 
Member States
3 or in third countries which had imported animals or animal feed 
from the United Kingdom. 
2 
3 
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36  681  cases  in  1992 1  14  076  cases  in  1995 1  and  a 'total  of  163  071 
cases  in  33  657  farms  at  6/9/1996  The  estimated  incidence  for  1996 
is  8  270  - see  Annex  IV. 
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3 (5)  The  infectious  agent  responsible  for  BSE  has  not  yet  been  identified.  It is 
generally considered to  be a protein known as  a "prion". This prion possesses 
exceptional  characteristics,  such  as  resistance  to  heat,  ultraviolet  and  ionising 
radiation and chemical disinfectants. 
(6)  According to the generally accepted scientific exphination, the BSE epidemic in 
the United Kingdom first originated in the recycling of contaminated bovine and 
ovine tissues processed into animal feed in the form of meat and bone meal, and 
in  changes  in  the  methods  of producin' t¥ese  meals  in  the  early  eighties  -
specifically  the  reduction  in  the  duration  of treatment  and  treatment  at  lower 
temperatures. 
.(7)  } 
(8) 
(9) 
These changes are thought to have been caused by the transmission of the sheep 
scrapie agent to  bovine animals,  or by the  multiplication  and  propagation of a 
hitherto unidentified disease already present ih bovine animals. Thus the f~eding 
of ruminants  with  ruminant.· proteins  was  outlawed  in  the  United  Kingdom  in 
1988.  Most of the  Member  States  foll~wed suit in  the  early  nineties,  and  the 
official ban for the Community as a whole was declared in 1994. 
Other possibilities of transmission: so  far there is  no  conclusive .evidence that 
the disease can be transmitted either horizontally, i.e. from one animal to another, 
or vertically,  from  cow  to  calf.  A  large  scale  multi-year experiment has  been 
launched in the United Kingdom to study the possibility of vertical transmission 
arid  research  work  is  also  being  done  into  the  possibilities  of  horizontal 
transmission. According to the results published in August 1996 concerning cows · 
born to contaminated cows, there is a possibility of maternal transmission but it is 
very  low.  The  results  of these  studies.  are  currently . being  examined  by  the 
Scientific  Veterinary  Committee  (SVC), and  the  Multi-disciplinary  Scientific 
Committee (MSC). 
Transmissibility between different animal species:  in the case of BSE, crossing 
of the  species  barrier  is  the  subject  of numerous  evaluations.  It has  been 
· possible  to  produce  spongiform  encephalopathies  using  contaminated  bovine 
materials in the pig, the mink, the sheep and the monkey in a laboratory setting. 
However, it has never been demonstrated that such transmissibility is possible in 
the natural state, i.e. other than in  e~perimental conditions. 
Infected organs:  infectivity has been identified in a limited number of organs. 
In  bovine animals:  the brain,  the spinal  cord,  the  eyes  and  certain  parts  of the 
intestine. In sheep and goats, the spleen may also be infected. However, no trace 
of infectivity has  been found  in  other organs or fluids,. notably meat,  milk and 
semen. 
4 I, 
I  B.  WHAT IS SCRAPIE? 
-- (10)'  Scrapie is  an  animal  spongiform  encephalopathy which affects  ovine  animals 
and goats. 
( 11) 
(12) 
I  c. 
(13) 
(14) 
Known for almost three centuries
4
,  this  epizootic differs from  BSE in that one 
animal  can transmit it to  another (horizontal transmissibility) and the  ewe can 
transmit it to  its  lamb  (vertical transmissibi-lity).  It is  found  in  several Member 
States and in most continents.· 
Is  this  disease transmissible to  humans?  Given the relatively high incidence of 
this  epizootic  in  many  countries  and  the  fact  that  it  has  affected  herds  for 
centuries, it is  reasonable to assume that if it were transmissible to humans this 
feature  would  long  have  been  scientifically  established.  Hence  it  may  be 
considered that, on the basis of epidemiological data,  classical scrapie poses no 
danger to man. 
However,  research  done  in  the United Kingdom  in  1996  has  shown  that it  is 
possible to transmit BSE to  sheep through food consumption in an experimental 
setting.  Some scientists think that the scrapie currently diagnosed in the United 
Kingdom may be a variant of BSE caused by the consumption of contaminated-
meal. One cannot rule out the possibility that sheep that have eaten  infecte~ meat 
and  bone  meal  may  have  been  infected  by  BSE.  However,  this  is  only  a 
hypothesis, especially since it is relatively unusual for ovine animals to eat meal. 
WHATISCJD? 
Creutzfeldt-Jakob disease (CJD) is  an incurable and fatal neurological disease 
affecting  humans.  It  belongs  to  the  family  of  human  spongiform 
encephalopathies, which also includes kuru and two rare genetic diseases. It was 
first identified in the twenti-es and is a worldwide phenomenon, with an incidence 
of the order of one case per million per year. There are two forms of the disease: 
classical CJD and a new variant, recently identified, known as V-CJD. 
Classical CJD can be divided into three categories: a sporadic form (about 85% 
of all  CJD  cases);  forms  associated  with genetic predisposition  (some  1  Oo/o  of 
cases);  and  iatrogenic  transmission  resulting from  the transmission of infected 
human tissue, for example corneal grafts, or the practice during the early  1980s 
of using  growth  hormones  obtained  from  human  cadavers  to  treat  growth 
deficiencies. The sporadic and genetic forms of CJD almost always affect elderly 
4
Scrapie was recognised for the first time in 1732 in the United Kingdom. 
5 people (mean age of onset about 65). In general, patients die four to six months 
after the onset of the disease. ·Currently there is  no scientific evidence of a link 
between the  onset of classical  CJD  and  the  appearance  of animal  spongiform 
encephalopathies or dietary habits such as the eating of animal brains. 
( 15)  In  199  5 the CJD surveillance unit in Edinburgh identified 1  0 cases of a form of 
CJD_ sufficiently distinct from  classical CJD to  be_ described  as  a new variant. 
These patients were all young (ranging from  19 to 41  years, with an average age 
of 29 years), the disease ·was of relatively long duration ( 13  months on average), 
it  presented  a  clinical  model  differing  from  classical  CJD,  and  distinctive 
pathological  characteristics  were  observed  at  autopsy  ..  The  s·cientists  studying 
these cases have found nothing in the patients' medical history, genetic analyses 
or other factors  which  could  explain these cases.  The United Kingdom's  BSE 
Advisory Committee examined these cases and concluded on 20 March 1996 that 
"although there is no direct evidence of a link, on current data and in the absence 
of any  credible alternative  the  most likely  explanation  at  present  is  that  these 
cases are linked to exposure to BSE before the introduction of the SBO ban (i.e. 
prohibition of the use of certain specified bovine offals) in  1989".  The British 
Advisory  Committee's  conclusion  therefore  reinforces  concern  about  the 
transmissibility of the  pathogenic BSE agent to  man.  Since  then,  one case of 
V  -CJD  has  also  been  confirmed  in France  and  four  new  cases  in  the  United 
Kingdom, making a total of 15  cases to date.  No case has been identified in  any 
other country. 
(16)  On  2  and  3  April  1996,  the  World  Health  Organisation  (WHO)  called  a 
meeting of experts on BSE and V-CJD.  They confirmed that the most plausible 
hypothesis  for  the  appearance  of V-CJD  was  the  United  Kingdom  population 
being exposed to BSE, but they stressed that no such link had so far been proved. 
These experts  also  concluded that "the risk,  if there is  one,  of exposure to  the 
BSE agent in other countries must be regarded as being lower than in the United 
Kingdom. Exposure to the BSE agent in the United Kingdom was likely to have 
been higher before the BSE regulations now in force".  Studies conducted by the 
-Imperial  College  of London  and  published  in  the  24 October 1996  issue  of 
Nature  seem  to  confirm  that  BSE  can  be  transmitted  from  cattle .to  humans. 
These findings, which need to be corroborated by other tests,· are currently being 
studied  by  the  Commission's,  Multi-disciplinary  Sci{mtific  Committee  and 
Scientific Veterinary Committee. 
6 I  D.  MEASURESTAKENTOCONTROLBSE 
a.  Measures taken before 20 March 1996 
(17)  The most important move to protect both human and animal health, introduced in 
the  United  Kingdom  in  1988  and  in  other  Member  States  in  which  BSE 
subsequently appeared,  was  the slaughter and destruction of animals eitber 
infected or liable to be infected
5
.  Moreover,  the United Kingdom banned the 
use of ruminant protein in  ruminant feed and,  in  1989, the use in human food of 
certain  bovine tissues  (specifi'ed  bovine  offals,  including the  brain  and  spinal 
cord) from bovine animals aged over six months.  This action removed from the 
'human and animal food chains the raw material most likely to present a danger of 
transmitting the disease. 
( 18)  Since 1988, other measures have been implemented by the British Government 
and by the Community in order to prevent the spread ofBSE a:nd to minimise any 
risk to human health. These measures are summarised in the annexes. Principally, 
they involve withdrawing infected or potentially infected bovine tissue from the 
human food  chain and  stopping the epizootic from  spreading to  other Member 
States or third countries. 
( 19)  Community measures to prevent the spread of BSE to other countries have been 
successful,  since  less  than  0.50%  of cases.  have  occurred  outside  the  United 
Kingdom. The measures taken within the United Kingdom to  control the disease, 
notably the ban on feeding ruminants with infecte-d feed, have also been relatively 
effective,  because the  incidence  of BSE declined  by  over 60%  from  1992  to 
1995.  However it is  clear that this  ban has  not been fully  observed because  a 
significant number
6 of  BSE cases have occurred in livestock born after the ban. 
b.  Measures following the 20 March 1996 announcement by the United 
Kingdom authorities 
(20)  Within  a  few  days  of the  20  March  announcement,  the  other Member  States 
adopted  protective  measures  with  regard  to  British  cattle,  beef and  veal,  and 
bovine products.  Despite  this  sales  of beef'  and  veal  in  most  Member  States 
plummeted.  In  the  wake  of these  national  measures  and  after  consulting  the 
Scientific  Veterinary  Committee  on  22 March,  the  Commission  convened  a 
meeting of the Standing Veterinary Committee· on 25  and 26 March to  elicit its 
opinion on  the  adoption of Community  protective  measures.  The Commission 
then adopted Decision 96/239/EC on 27 March. 
5 
6 
In  France,  Ireland  and  Portugal  the  authorities  are  proceeding  to 
slaughter all herds  in which  a  case is diagnosed. 
Approximately  27  000  cases. 
7 (21)  Pending an overall examination of the situation, Decision 96/23 9/EC imposed a 
temporary  ban on  United Kingdom  exports  to  other Member  States  and  third 
countries of live cattle, their semen and embryos, meat and meat products from 
cattle slaughtered  in  the United Kingdom  and  intended  for  human  and  animal 
consumption, together with) medicinal, cosmetic or pharmaceutical
7 products and 
mammalian meat and bone meal. All Member States were required to modify the 
measures they  had  adopted,  to  bring them  into  line with this  Decision,  and  to 
notify the Commission when they had done so.  Moreover, the United Kingdom 
was required to report every two weeks to the Commission qn the application of 
national  and  Community  measures  to  control  BSE and  was  invited  to  present 
supplementary proposals for the control of  BSE within the United Kingdom. 
(22)  The Council of the Ministers of Agriculture that met in Luxembourg on 1, 2 
and 3 April adopted a further series of measures: 
.7 
8 
for the United Kingdom:  various measures as  part of the global plan to 
eradicate BSE in the United Kingdom adopted in Florence
8 
· 
for the Community as a whole: 
the treatment of animal wastes  in  order to  inactivate the scrapie 
and B SE agents, 
the  labelling  of  mammalian-derived  meat  and  bone  meal  to 
exclude their use as feed for ruminants, 
the  introduction of a system  of meat labelling to  meet  growing 
consumer  concern  with  regard  to  the  production  methods  and 
source of food products, 
the  intensification  of research  into  BSE,  the  Commission  being 
asked to submit a list of priorities before 1 July 1996 . 
Commission  Decision  No  96/362/EC  (see  section  34)  of  11  June  1996 
specifies  in  regard  to  the  latter  that  this  concerns  "materials 
obtained  from  bovine  animals  slaughtered  in  the  United  Kingdom, 
destined for use  in cosmetic,  medicina~ or  pharma~eutical products". 
See  sections  25  and  26  below. (23)  The Agriculture Council of 29  and 30 April confirmed the approach adopted 
earlier and  reviewed  developments.  The  ban on  United  Kingdom  exports  was 
upheld  as  a  safeguard  measure.  The  United  Kingdom  submitted  a  selective 
slaughter  programme. ·Discussions  are  still  continuing  on  this  programme.  At 
scientific  level,  the  Council  underlined  the  need  to  continue  research  into  a 
possible  link  between  BSE  and  CJD  and  called  for  the  creation  as  soon  as 
possible  of a  multidisciplinary  scientific  committee  (human  and  veterinary 
medicine,  public and  animal  health,  toxicology and  biology) in  order to  obtain 
scientific advice and  recommendations on the various  issues  falling within the 
Community's jurisdiction. 
(24)  On 28 May" the Commission also sent an inspection team to the United Kingdom 
to  assess  the measures  taken  there  to  tackle  the  crisis  in  accordance with the 
Community decisions.  Other  inspections  followed  in  July  and  subsequently  in . 
September-October in the United Kingdom, but also in other Member States. 
(25)  Emphasising  its  approval  of  the  framework  for  action  presented  by  the 
Commission to  eradicate BSE. in  the United Kingdom, the Florence European 
Council  of 21  and  22  J~ne 1996  of the  Heads  of State  and  Government 
addressed the political difficulties associated with this issue.  It was agreed that, 
once established, this framework for action would lead to  a gradual relaxation 
of the restrictions currently  governing the export of United  Kingdom  bovine 
products towards the rest of the European Union and third countries. To this end 
the  Commission  will  submit  appropriate  decisions  when  it  considers  that  the 
necessary conditions, based on scientific and technical opinions, are met, These 
decisions will be adopted uniquely and  exclusively on the basis of public health 
criteria and objective scientific criteria. 
(26)  The action plan envisages: 
the  mandatory  selective  slaughtering  of_ animals  and/or  herds  of birth 
cohorts born between 1989 and  1993 which have been identified as  most 
liable  to  have  been  exposed  to  infected  meat  and  bone  meal. 
Approximately 140 000 bovine animals will be slaughtered. 
the  introduction  of an  improved  system  of individual  identification  of 
bovine animals to  ensure effective surveillance of their movements  and 
their traceability (passport system), 
more stringent controls of firms that manufacture animal feed, 
a detailed veterinary study of each farm which is or has been affected by 
BSE, to identify the cohort animals to be slaughtered. 
9 These  measures  are  in · addition  to  the  measures  already  adopted  by  the 
Agriculture Council on  1,  2 and 3 April and 29 and 30 April in regard to the 
United Kingdom: 
destruction of  bovine animals aged over 3  0 months, 
the elimination of specified offals
9  of bovine animals  younger than 30 
months,  , 
the tightening of veterinary controls, 
payment  by  the  Community  of  70%  of the  value  of  compulsorily 
slaughtered animals. 
(27)  The  British  requests  for  a  review  of  t~e  slaughtering  plan  following  the 
experimental results obtained in September have been submitted to the Scientific 
Veterinary  Committee  and  the  Multi-disciplinary  Scientific  Committee  for 
examination. In the meantime, as  far as  the Commission  i~ concerned, the plan 
rem~ins fully applicable. 
E.  CAN THE BAN ON CERTAIN PRODUCTS COVERED BY THE DECISION OF 
27 MARCH BE LIFTED? 
(28)  Traditionally the Commission has always cori.sidered that consumers should have 
the benefit of the doubt in the case of misgivings as to a product's safety.  On the 
other hand, when a product is  believed to be safe the Commission considers that 
there can be no  grounds for challenging its  manufacture and distribution under 
the appropriate conditions.  At the Florence Summit of 21  and 22 June 1996, the 
European Council
10  confirmed this principle and  envisaged the possibility of a 
gradual relaxation of the restrictions currently governing the export of United 
Kingdom  bovine  products  towards  the  rest  of the  European  Union  and  third 
countries.  In  this  connection  the  Commission  will  take  into  account  the 
recommendations submitted to it by the competent scientific committees which 
it  has  created  and  whose  scientific  status  and ·total  independence  are  assured. 
Hence the Commission was  invited  to  consider a  part@l  lifting of the ban on 
semen, gelatine, tallow and derived or similar products. 
9 
10 
The  specified  offals  of  bovine  animals  include  the  brain 1  spinal 
cord 1  thymus 1  tonsils 1  spleen  and  the  intestines. 
See  section 25. 
10 
.· (29)  These assessments were  carried  out at  Community  level  as  soon  as  the  crisis 
arose. The relevant experts in the Member States for the various types of product 
met  in  the  BSE-related  committees  under  the  aegis  of the  Commission  (see 
annex). With the utmost caution and even though there is no proof that BSE can 
be transmitted to humans, they have consistently recommended that all measures 
taken should help to  reduce the risk of human- exposure to  the infective agent, 
acting on the assumption that transmission is possible. 
(30)  As  regards  bovine semen,  it was  decided  to  lift  the  ban because  no  trace of 
infectivity has  ever been found.  The  Scientific Veterinary Committee therefore 
concluded  that  this  product  is  not  a  danger  to  animal  health- as  regards  the 
transmission  of  BSE.  In  c~mpliance  with  the  provisions  of 
Directive 88/407  /EEC, semen will be taken only from bulls certified as healthy. 
(3 1)  Gelatine and  tallow are used in  the manufacture of or as  ingredients  in  many 
industrial products,  including a large number of foodstuffs,  drugs  and  cosmetic 
products. It was therefore necessary to investigate whether such products can or 
could  have contained  a raw material  infected  with the  BSE  agent  and  then to 
assess the associated risks. 
(32)  On  26  April  the  Scientific  Veterinary  Committee  (SVC)  concluded  that  if a 
bovine material of appropriate origin is used and minimum standards of treatment 
are applied which have been proved to be genuinely effective in inactivating the 
BSE agent, these products can be considered as safe for use in food or cosmetics. 
Previously,  in  a  WHO  communication  dated  3 April  1996,  it  w&s  stated  that 
gelatine used in food  is  considered to  be safe if obtained using a manufacturing 
procedure shown to implement production conditions that definitively inactivate 
any residual infectivity which may have existed in the source tissue.  The WHO 
communication goes on to say that tallow is also considered to be safe if effective 
procedures are used to treat the cadavers. 
(33)  Foodstuffs, cosmetics  and  pharmaceutical products which  include  gelatine, 
tallow or other' similar or derived products are also considered to be safe provided 
the ingredients are themselves safe. 
(34)  This  is  why  the  Commission  has  adopted  a  new  decision  amending  that  of. 
27 March 1996 and authorising a conditional and partial lifting of the ban.  This 
decision 
11  was taken on 11 June 1996 and published in the Official Journal of  the 
European Communities the next day
12
. 
11 
12 
Pursuant to this decision,  all British bovine products covered by the decision of -
27 March remained banned with the exception of: 
bovine semen 
Commission Decision  96/362/EC  of  11  June  1996 
OJ  EC  No  L  139,  12  June  1996. 
11 gelatine,  tallow  and  similar  or  derived  products 
13  obtained  us1ng  the 
specified manufacturing processes 
products of  which they are an ingredient. 
Hence  this  a  partial, conditional  and strictly limited  lifting of the  ban  on 
exports of  British bovine products. 
(35)  It.  is  also  specified that,  in  the  manufacture of gelatine,  tallow  and  similar or 
derived products, the following may not be used as  raw materials in the United 
Kingdom: 
bovine animals over 3 0 months of  age 
tissues
14  susceptible  of infectivity  from. bovine  animals  aged  less  than 
30 m·onths 
bovine animals suffering from BSE or suspected of having BSE. 
Finally, the manufacturing conditions, i.e.  pH,  temperature, pressure,  duration 
of treatment,  specified  in  the Annex  to  the  Decision,  must  aJso  be such as  to 
ensure the products' safety. 
(36)  However the ban has not yet effectively been lifted.  Not enough scientific work 
has  been  done  to  validate  the  effectiveness  of the  method.  Therefore  further 
studies  will  be  conducted  and  the  dossier  will  be forwarded  to  the  Scientific 
Veterinary  Committee  and  the  Multi-disciplinary  Scientific  Committee  for 
evaluation. 
Hence the ban on exports of gelatine and derived products will not be effectively 
lifted  until  the  situation  has  been  clarified  and  a  safe  method  of gelatine 
manufacture clearly defined. 
(3 7)  When this condition is met, the ban will be lifted in five stages. 
13 
14 
I.  the United Kingdom must have ensured: 
control of  the production units, 
an appropriate labelling system; 
2.  the  United  Kingdom  must  have  notified  the  Commission  and  must 
forward  to  the  Commission  and  the  Member  States  the  list  of 
establishments  under  veterinary  control  which  can  meet  the 
manufacturing conditions; 
'Gelatine  and  di-calcium  phosphate,  amino  acids  and  peptides  produced 
from  hides  and  skins;  tallow  and  tallow  products  and  certain  foods 
additives  and  products used  in the  manufacture  of  medicines. 
Skull,  vertebral  column,  brain,  spinal  cord,  eye,  tonsil,  thymus, 
intestine,  spleen. 
12 3.  the Commission must have carried out Community inspections to verify 
that the manufacturing and  control systems have been established in the 
United  Kingdom.  Member  State  experts  will  participate  in  these 
inspections; 
4.  the Standing Veterinary Committee must have been consulted; 
5.  the.Commission must have laid down on a case by case basis, i.e. for each 
individual product and  establishment,  the  date on which dispatch of the 
product is to recommence. 
It is only then that the ban will be lifted for these products. 
I  F.  . . THE SITUATION AS REGARDS OTHER BOVINE PRODUCTS 
(38)  Except for  milk and  dairy  products  and  products which do  not enter the food 
chain such as  leathers and skins, the United Kingdom may not dispatch from its 
territory  to  the  other  Mem~er States  or  third  countries  any  bovine  product 
obtained from cattle slaughtered on its territory. This is required by  Commission 
Decision 96/239/EC of 27 March 1996 and is still fully applicable today. 
(39)  Milk and dairy products are not covered by the decision of 27 March 1996. Milk 
and dairy products from animals infected with BSE have shown no signs of being 
infected and the data on other animal  and human spongiform encephalopathies 
indicate that milk does not pass on these diseases.  Milk and  dairy  products are 
therefore considered to be safe even in countries with a high incidence of  BSE. 
These are the conclusions of  the WHO communique of 3 April 1996. 
(40)  The same applies to  products that do  not enter the ·human or animal food  chain 
such as leathers and skins. 
(  41)  In  all  the Member States,  including the United Kingdom,  ongoing experiments 
have not s·hown  any  infectivity of beef and  provide no  evidence that meat can 
transmit BSE.  Moreover the  measures  taken  since  the  appearance of BSE and 
notably  since  20 March  have  further  enhanced  the  safety  of meat  and  derived 
products.  The  national  and  Community  authorities  reckon  that  the  risks  of 
contamination from  the  consumption of beef are  practically zero.  However for 
·precautionary reasons,  and until every safeguard has been obtained, there can be 
no  question  of authorising  the  exportation  of beef or beef products  from  the 
United Kingdom. 
13 (  42)  Since 1989 in the United Kingdom, specified bovine offals and specifically the 
brain, spinal cord, thymus, tonsils, spleen and the intestines have been banned for 
human consumption. These offals must be carefully removed from the carcasses 
of  bovine  animals  intended  for  consumption  and  then  destroyed.  As  a 
precautionary measure the Commission in July  1996 discussed at the Council of 
Agriculture Ministers the banning of bovine offals as well as offals of sheep and 
goats in all the Member States. This question is  currently being examined by the 
Scientific Veterinary Committee and the Multi-disciplinary Scientific Committee. 
fG 
(43) 
(44) 
15 
WHAT SUPPLEMENTARY MEASURES MAY BE ENVISAGED?  ·I 
a.  In the agricultural sector 
As  indicated  in  Sections 22  and  23,  on  3  and  30  April  1996  the  Agriculture 
Council  adopted the framework for  all  the necessary  measures,  including both 
immediate and longer term ones. It emphasised in particular the need  t~ improve 
the tagging and traceability of bovine animals and bovine products in order to 
develop a genuine passport and to introduce a labelling system for beef and beef 
products to  accommodate consumers'  concerns  with  regard to  food  production 
methods  and  sources.  Voluntary  measures  will  be  encouraged  in  this  domain. 
Two  proposals  for ·regulations 
15  were  thus  adopted  by  the  Commission  on 
2 October and presented to the Council (COM(96) 460 final). 
The Council  has  also  stressed  the  need·  to  intensify  research  work  in  order to 
answer  many  of the  outstanding  questions  concerning  BSE.  It welcomed  the 
measures taken by  the  Commission relating. to  the remit of the Working Party 
chaired by Professor Charles Weissmann from the University of Zurich and to 
the. earliest possible  establishment of a multi-disciplinary  scientific  committee. 
The  Weissmann  Working  Party  was  created  in  April  1996  and  submitted  its 
report  to  the  Commission  on  7 October.  The  Multi-disciplinary  Scientific 
Committee, which was created on the basis of a decision taken on  18 June, will 
have  met  five  times  in  1996.  It  is  chaired  by  Dr F. H. Kemper  from  the 
University of Muenster. 
Proposals  for  Council  Regulations: 
establishing  a  system  for  the  identification  and  registration 
of  bovine  animals 
regarding  the  labelling of  beef  and  beef  products 
14 
.. (  45)  The Council is  currently examining a proposal for a regulation 
16  on the creation 
of a  European Agency for Veterinary and Phytosanitary Inspection.  The 
main task. of this  agency will be to  carry out inspections in the Community to 
ensure the uniform application of  Community animal and plant health legislation. 
b.  In the health sector 
(46)  The Council of.Health Ministers addressed the question of TSEs  (transmissible 
spongiform  encephalopathies)  on  13 December 1993  and  3  0 April 1994.  in 
response  to  German  public  health  concerns~ they  focused  on  epidemiological 
surveillance and the need for scientific ·research. 
(47)  The  Council  of Health  Ministers  of 14  May  1996  welcomed  the fact  that the 
question of TSEs, which is a public health problem deserving the utmost priority, 
had again been drawn to its attention by a Commission document with an eye to 
discussing appropriate measures. 
(  48)  In its conclusions the Council recommends in particular the following: 
(49) 
16 
implement  measures  to  monitor  the  scientific  evidence  relating  to  the 
causes  and  transmission  of  CJD  so  that  appropriate  public  health 
protection measures can be determined in a timely manner; 
extend the epidemiological surveillance of CJD to all the Member States 
using the same methods as have been applied in five Member States; 
encourage exchanges between Member States, of experience and expertise 
in the areas of control and diagnosis of cases; 
conduct further additional studies and research into TSEs, including CJD. 
The  Council  also  decided  to follow  up this question  on  a  permanent basis. 
Hence the dossier will be re-examined by the Health Ministers at the next Health 
Council  meeting  on  12  November  1996,  with  particular  attention  to  the 
epidemiology  of the  Creutzfeldt-Jakob  Disease  in  the  Member  States  of the 
European Union. 
Proposal  for  a  Council  regulation  presented  by  the  Commission  on  11 
July 1996,  published  in  OJ~C No  C  239  of  17/8/96. 
15 (50)  In this context the reference to the protection of public health in the order of the 
Eur,op_ean  Court of Justice of 12 July 1996 on "Application for interim relief-
Agriculture - Animal Health - Emergency measures  against bovine spongiform 
encephalopathy"  is  of the  essence.  According  to  the  Court  the  circumstances 
show that the Commission's  primary  concern  is  to  protect public health in the 
framework  of the  single  market,  as  is  its  duty  under  Directives 90/425  and 
89/662.  Here  it  should  be  noted  that  the  EC  Treaty
17
.  includes  among  the 
Community's objectives that of contributing to  the attainment of a high level of 
health protection, that it states that "the Cltnmunity shall contribute to assuring a 
high level of human health protection"
18
,  and that health frotection requirements 
form a constituent part of  the Community's other policies 
1 
.  · 
c.  In the research sector 
(51)  At national level, research in the field of spongiform encephalopathy has been 
addressed at .two levels: 
1.  clinical  research  and  surveillance of human  spongiform  encephalopathy 
thanks  to  the  creation  of national  reference  centres  to  record  and 
evaluate all  possible cases of the disease.  Hence the new variant of CJD 
was  made was  identified at the British national  reference centre,  which 
also coordinates the CJD surveillance project at European level. 
2.  Basic  research  on  human  and  animal  spongiform  encephalopathy 
addressing  questions  such  as  the  structure  and  function  of the  prion 
protein, the mechanisms of the disease's transmission, the development of 
transgenic models which can be used as models for human prion diseases, 
and the search for diagnostic tools. 
(52)  At Community level these efforts have been underpinned by the creation of six 
research  centres which,  since  1992,  have  been  addressing  questions  relating to 
CJD surveillance, the harmonisation of neuropathological diagnostic criteria and 
17 
18 
19 
· the use of animal models to .identify the nature of the agent and the effectiveness 
of  the inter-species barrier. 
This Community action has  imp~ov_ed the system for monitoring CJD and related 
diseases  in the  countries concerned,  has  made  it  possible to draw comparisons 
between  countries  and  to  develop  harmonised  procedures  for  identifying  and 
characterising  the  disease.  Hence  such  a  structure  can  be  used  as  a  basis  for 
developing  standard  procedures  for  the  identification -and  surveillance  of the 
disease at the level of all the Member States. 
Article  3 (o)  of  the  EC  Treaty. 
Article  129 (1) 1  subparagraph 1. 
Article  129 (1) 1  subparagraph  3. 
16 '  '  -
(53)  A meeting of the Directors-General-of Research in  the Member States was 
held  on  5  June.  The  meeting  focused  on  the  pooling  of  information  and 
viewpoints  concerning  ongoing  research  at  national  and . European  level,  the 
objective being to create a mechanism to strengthen cooperation and coordination 
i~  this·  domain.  On  this  occasion  the  Commission  was  requested  to  make 
arrangements to coordinate the collection of information on ongoing research and 
to create a rapidly as  possible an information system on research problems.  The 
Member States also proposed that the Commission provide additional resources 
and  consider launching a special  call  for proposals designed to  encourage new 
ventures in this domain. 
(54)  In this context the Commission has  prepared an  action plan geared primarily to 
enhancing the coordination of research work in the Member States, notably with 
a view to improving the surveillance, early detection and diagnosis of CJD.  This 
action plan is to be examined by the "Research" Council on 5 December 1996. 
d.  In the cosmetic products sector 
(55)  The  Commission  is  currently  preparing  a  proposal  for  a Directive pursuant to 
which Member States must take the necessary measures to ensure that as of 1 July 
1997  cosmetic  products  containing  tissues  or fluids  from  the  encephalon,  the 
spinal  cord or· the eyes of bovine animals,  ovine animals or goats  and  derived 
ingredie!lts may no-longer be placed on the market. The measure will be adopted 
on a precautionary basis for a period of  two years, with the possibility of renewal. 
The Scientific Committee on Cosmetology was consulted on 2 October 1996 and 
concluded that risks linked to the utilisation of these products cannot be excluded 
and delivered a favourable opinion on the measures proposed by the Commission 
based on the precautionary princ~ple and justified on grounds of public h,ealth. 
I  H  CONCLUSIONS 
(56)  The fact that cattle and the parts most likely to  be contaminated did in the past · 
enter the food chain, particularly in the United Kingdom, gives rise to legitimate 
_concern about past exposure. 
(57)  The studies have only shown that infective ·properties-are  limited to  the brain, 
spinal cord, retina and part of the intestine. This is why these products have been 
banned  from  human  food  in  the  United  Kingdom  since  1989.  Other  parts  or 
products of bovine origin, particularly meat and milk, have not been found to be 
infective. 
17 (58)  Research  work  on  the  possibilities  of transmission  is  being  continued.  The 
Commission's Interdepartmental Working Party is monitoring scientific progress 
so  as  to  keep  consumers  abreast  of  events  and  to  issue  appropriate 
recommendations as soon as possible. 
(59)  Since 20  March  1996  the European Commission has  convened the Consumer 
Committee on three occasions and has entered the BSE question on the agenda 
of each  ~eeting with  an  eye -to  informing the consumer representatives of the 
measures taken and to eliciting information as  to  the measures consumers want. 
The Committee has proposed to the Commission the annexed resolution
20
. As can 
be seen from  the Guide,  several proposals  in  this  resolution have already been 
approved by the Commission and some of them are being implemented right now 
(a reply will be given to the Committ~e  at a forthcoming meeting). 
(60)  In conclusion, the Interdepartmental Working Party would impress on consumers 
the Commission's determination: 
to do its utmost to answer the questions raised by BSE and in particular: 
to  involve  in  its  efforts  to  protect  consumer  health  all  the  appropriate 
authorities, including organisations representing consumers; 
to  intensify  scientific  research  and  to  take  such  measures  as  appear 
justified in the light of  the findings; 
to inform consumers as fully, accurately and clearly as possible. 
Lastly  the  Interdepartmental  Working  Party  reaffirms  that  the  Commission's  primary 
objective is to safeguard public health and to keep consumers properly informed.  · 
20 
See  Annex  III  "Resolution of  the  Consumer  Committee". 
18 
"" ANNEX I 
Bovine spongiform encephalopathy: an overview of measures 
taken by the Commission and the Council 
to protect consumers 
Since bovine spongiform encephalopathy appeared in the United Kingdom in  1986, and 
as  scientific knowledge has  advanced,  the  Commission  and  the  Council  have  taken  a 
wide range of measures to prqtect consumer health and to eradicate the epidemic. 
Here, in chronological order, are the main Commission Decisions involved. 
21 
22 
23 
24 
25 
The Decision of 28  July  1989
21  banning the export of live cattle born  prior to 
18 July 1988  or born to  cows  suspected of having BSE.  Subsequent Decisions 
modifying  or  providing  for  more  detailed  implementation  of this  measure 
culminated  in  the  Decision of 27 March 1996
22
,  which ordered  the  provisional 
cessation of all  exports of live cattle,  beef, veal and beef-derived products from 
the United Kingdom to other Member States and third countries. 
The Decision of 9 April 1990
23  requiring in particular the separate retention and 
slaughtering of all  cattle suspected of having B  SE,  an examination of their brain 
tissue to determine whether BSE was present and, on confirmation of  the disease, 
the destruction of the carcass and  offal.  The Decision also  regulated the export 
from  the United Kingdom to  other Member States of other tissues  and  organs 
from cattle aged over six months at slaughter. 
The Decision of 8 June  1990
24
,  in  particular requiring the  United  Kingdom to 
n1ake full use of computer records to guarantee identification of animals. 
The Decision of 27 June 1994
25  banning, with effect from 27 July 1994, the use 
in  any  Member State of animal feed  containing protein derived  from  ruminant 
tissue. Where identification of the tissue was difficult, the ban was  extended to 
tissue from any mammal. 
Decision  89/469/EEC  (OJ  No  L  225,  3.8.1989,  p.  51) 
Decision  96/239/EEC  (OJ  No  L  78,  28 .3 .19961  p.  47) . 
Decision  90/200/EEC  (OJ  No  L  105,  25.4.1990,  p.  24) . 
Decision  90/261/EEC  (OJ  No  L  105,  25.4.1990,  p.  24) . 
Decision  90/381/EEC  (OJ  No  L  146,  9.6.1990,  p.  29) . 
19 The  Decision  of  27  June- 1994
26  setting  out  mtntmum  conditions  for  the 
processing of  ruminant wastes so as to inactivate the BSE agents; 
The  Decision  of 27  July  1994
27  requiring  the  United Kingdom  to  destroy 
specified bovine offals (brain,  spinal cord, thymus, t9nsils, spleen,  intestiqes) of 
cattle aged over six months. 
At the same time, in order to take the fullest possible account of  the opinions of scientists 
and  experts,  me~tings of the  Commission  committees  involved in BSE were held as 
often as was helpful. The committees primarily involved since 20 March 1996 are: 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
the Consumer Committee, 
the ·Scien~ific Committee on Cosmetology, 
the :Scientific Committee for Food, 
the.  Scientific  Committees  of the  European  Medicines  Evaluation  Agency: 
Committee  for  Proprietary  Medicinal  Products  and  Committee  for  Veterinary 
Medicinal Products, 
the ~Scientific Veterinary Committee, 
the Scientific Committee for Animal Nutrition, 
the  Gro~p of Government Scientific Experts on the Protection of Workers from 
the Risks related to Exposure to Biological Agents at Work, 
the 'Working Party on Cosmetic Products, 
the ,"General Product Safety'' Emergencies Committee 
the 'High Level Committee on Public Health 
the Pharmaceutical Committee, 
the .Standing Veterinary Committee, 
the :Management Committee for Beef and Veal. 
the Standing Committee for Foodstuffs  . 
In  addition  to  these  committees  there  is  the  Scientific  Multi-disciplinary  Committee 
created on 18 June 1996 and the Working Party of scientific experts chaired by Professor 
Charles Weissmann. 
26 
27 
Decision  94/382/EEC  (OJ  No  L  172,  7.7.1994,  p.  25). 
Decision  94/474/EEC. 
20 ANNEXD 
MEASURES TAKEN BY THE BRITISH GOVERNMENT 
1988  BSE made  a notifiable  disease,  with  slaughter  and  destruction  of suspect  and 
confirmed cases. 
Ban on feeding ruminant protein to ruminants. 
1989  Ban on the use of specified bovine offals in human food. 
1990  New requirements for.  livestock breeding and  movement records to  be kept by 
farmers. 
1995  Tighter controls on the keeping and presentation of records 
Ban on removal of brains or eyes (whole skull becomes an SBO). 
Ban on mechanical recovery of  meat from vertebral column. 
1996  Ban on marketing of meat from cattle aged over 30 months. 
Ban on use of  mammalian meat-and-bone meal in feed for all farm animals. 
As  a result of public  co'ncern  about  the  safety  of UK  meat,  the  UK government has 
decided to exclude meat from animals slaughtered in the UK over the age of 30 months 
from the human and animal food chains as well as from cosmetics or pharmaceutical use. 
Meat and  carcases from  such animals must be destroyed.  This decision, when correctly 
and  effectively  implemented,  will  help,  in  accordance  with  the  Scientific  Veterinary 
Committee's recommendations, to significantly reduce the likelihood of human exposure-
to any infectious agent which might be present in such bovine tissues.  Effectively, this 
means that only animals born after 1 October 1993  may enter the food chain in the UK. 
This  date  will  move  forward  with time,  thus  further  reducing  the  likelihood  of such 
animals ever having been exposed to  infected meat and  bonemeal,  as  the ban on meat 
and bonemeal in ruminant feed takes ever greater effect. 
Furthermore, the United Kingdom has expanded the ban on the consumption of certain 
tissues  from  cattle over the age  of six  months with the result that,  in  addition to the 
above-mentioned tissues, the whole skull of the animal should now be destroyed. 
Taken together,  all  these measures should have effectively reduced the risk of human 
expo  sur~ to the infectious agent through the consumption of food. 
21 ANNEXEID 
BSE 
CONSUMER COMMITTEE RESOLUTION  (9 October 1996) 
I.  The CC  welcomes the Commission's  efforts to  improve consumer information 
about the background  and  the  current  situation  regarding the  BSE issue.  The 
members of  the CC took note of the Vademecum on BSE. 
2.  For consumer organisations public health and food safety issues must be the top 
priority. 
3.  Consumer organisations have argued from the beginning of the crisis in the late 
1980s  for  a  precautionary  approach to  the  consumer  health  and  safety  issues 
involved. 
Enforcement and inspection 
Consumer organisations stress the importance of the enforcement of all the rules 
and  controls on  slaughterhouses and· farms.  The safety of beef depends  on the 
implementation of  these controls. 
Resources  and  levels of inspection by national  meat hygiene services  must be 
adjusted to current requirements and, if necessary, increased with regard to BSE 
and the potential risk to human health. 
National control systems of procedures in slaughterhouses and  meat processing 
industries  must .be subject to  monitoring  at  EU level,  with  publication of the 
results of  the monitoring exercises. 
There should be more random inspections by EU appointed vets of standards in 
slaughterhouses throughout the EU. 
Animal feedstuffs and ruminant material 
Consumers  believe  that  it  is  fundamental  for  the  eradication  of BSE that all 
animal waste of mammalian origin in the Community should be processed by a 
method that has been demonstrated as being de facto effective for the inactivation 
of the agents of scrapie. This requirement is  laid down in Commission Directive 
96/449/EC of 18  July  1996 which shall apply from  1 April  1997.  We urge the 
Commission to provide guarantees regarding compliance with this decision from 
that date. 
22 In addition to the existing EU ban on the feeding of meat and bone meal derived 
from mammalian tissues to ruminant species, consumers request that no ruminant 
should be fed with feed containing animal protein. 
The EU should take steps to recall residual stocks of  feed that might contain meat 
and bone meal  origi~ating from  BSE infected animals,  both within the EU and 
from  third  countries.  Stock~ should  be  destroyed  in  such  a  way  as  that  they 
cannot re-enter the food chain. 
There should be EU legislation to  oblige feed  manufacturers  to  declare all  the 
ingredients of animal feeds. 
Levels and detection of tracing 
Consumers  request  the  full  implementation  of  Directive  92/102  on  the 
identification and registration of animals and assurance of the traceability of any 
movement of individual cattle both nationally and across frontier. 
Systems  assuring  that  meat  is  traceable  from  "the  table"  back  to  ·the 
slaughterhouse should be introduced. 
There should  be  an  EU wide  training  programme  to  enable  veterinarians  and 
farmers to recognise the symptoms of  BSE. 
Research 
Funds  allocated  to  independent  research,  concerning  the  underlying  causes  of . 
BSE, the possibility of transmission to other animals and to  humans  and of the 
process of transmission, should be increased. 
·.  The top research priority must be to develop a test for BSE which can be carried 
out on live animals.  If and when a live test is  develo.ped,  an  extensive El! wide 
test programme should be put into operation as soon as possible. 
Part of the funds  co~ld also be allocated to  the development of  a reliable system 
of epidemiological monitoring of BSE and to the collection of reliable statistical 
data of cases.· 
23 
~·' Labelling 
There should be a system of labelling for meat and meat products which makes 
clear what type of meat and from  what type of animal is  present in foods  (e.g. 
lambs liver).  Such a systell? should also allow for country of origin labelling for 
beef and beef products marketed to consumers. 
Manufacturers  should  be  required  to  declare  the  use  of any  Mechanically 
Reconstituted Meat (MRM), even below 25% of  the product. 
EU wide definitions of both meat and  :tviRM are needed to  prevent consumers 
from being misled. 
Product liability 
The  1985  EU  product  liability  Directive  excludes  liability  for  primary 
agricultural produce. It should be amended to cover primary agricultural produce 
in order to raise standards. 
Lack of public information 
· We consider that the growth of panic on the European beef market and the loss of 
consumer  confidence  are  largely  due  to  a  lack  of information,  or  partial  or 
contradictory  information.  This  is  why  consumers  should  be  assured  of the 
publication of the results of research and of a complete transparency with regard 
to the scientific elements on which the Community bases its decisions. 
We believe that consumers  should  be  given  correct,  complete  and  transparent 
information to enable them to make an informed .choice. 
One  possibility  could  be  the  creation  at  EU  level  of an  information  office · 
responsible for circulating data forwarded by the national sanitary authorities. 
Risk assessment 
As  long as  there are no  definitive scientific results,  the  precautionary principle 
should apply.  This means that measures to  cope with a risk must be based not 
only  on  solid  scientific  evidence  but  also  on  the existence of valid  scientific 
questions  that  have  not  yet  been  definitively  answered.  Measures  for  the 
protection of  human health must be designed to achieve the highest possible level 
of  protection. 
24 Consumer representation 
Consumers  ask  the  Commission  to  promote  consumer  representation  on  all 
scientific and consultative committees at EU level. 
EU food policy and production methods 
The BSE crisis stresses the consequences of an economic policy the objective of 
which is intensive productivity.  · 
One  contributing. factor  to  the  current  crisis  has  been  a  lack  of regard  for 
consumers'  preferences,  expectations  and  emotions  in  relation  to  food.  Policy 
makers ,have tended to dismiss these preferences and expectations unless they can 
be proved to  be fully  rational  and  based on  scientific  evidence.  Issues  such  as 
odgin,  production  methods,  processing  and  previous  history  of  food  can 
influence  consumer  attitudes,  yet  current  EU  food  policy  tends  to  ignore  the 
legitimacy of consumer concerns on these issues. 
We call therefore for an urgent review of food  policy (and particularly of food 
production and  distribution) in order to  meet more closely the expectations and 
preferences of 90nsumers.  On 29/30 April  1996, the Agriculture Council agreed 
that a long term  solution (to  the current crisis) requires,  inter alia, 
11production 
techniques which correspond to the legitimate expectations of consumers ... 
11
•  This 
conclusion shotJld be followed up immediately with practical action. 
25 
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